Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00640835 · ClinicalTrials.gov registry record · Phase 2
Safety and Tolerability of Buprenorphine/Naloxone Film Strips
A Phase 2 study, sponsored by Indivior.
- Completed
- Registry status
- Phase 2
- Development phase
- 382
- Enrollment target
NCT00640835 is a Phase 2 study that has completed, run by Indivior. The registered enrollment target is 382 participants.
The verdict
NCT00640835, a Phase 2 study, has completed, sponsored by Indivior.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 382 participants
- Enrollment target
Study Summary
This study will evaluate the safety and tolerability on the oral mucosa of buprenorphine/naloxone film strips administered either sublingually or buccally daily for 12 weeks in opioid dependent individuals who are already on a stable regimen of buprenorphine/naloxone.
Interventions
- DRUG Buprenorphine/naloxone Film Strip
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 382 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00640835
The ClinicalTrials.gov registry entry for NCT00640835 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 382 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indivior, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine/naloxone Film Strip is the first listed.
NCT00640835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00640835 about?
NCT00640835 is a clinical study titled "Safety and Tolerability of Buprenorphine/Naloxone Film Strips". This study will evaluate the safety and tolerability on the oral mucosa of buprenorphine/naloxone film strips administered either sublingually or buccally daily for 12 weeks in opioid dependent individuals who are already on a stable regimen of buprenorphine/naloxone.
What is the current status of trial NCT00640835?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 382 participants. The study started on 2008-02. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00640835?
The interventions under investigation include: Buprenorphine/naloxone Film Strip (DRUG).
Who is sponsoring clinical trial NCT00640835?
This trial is sponsored by Indivior, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.